PREDICTORS OF FATIGUE IN RHEUMATOID ARTHRITIS PATIENTSWHO RECEIVE BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

被引:0
|
作者
Freites Nunez, Dalifer [1 ,2 ]
Redondo, Marta [3 ]
Abasolo, Lydia [1 ,2 ]
Lois, Pia [1 ]
Hernandez, Isabel [1 ]
Vadillo, Cristina [1 ]
Leon, Leticia [2 ,3 ]
机构
[1] Hosp Clin San Carlos, Rheumatol, Madrid, Spain
[2] Sanitaria Hosp Clin San Carlos IdISSC, Inst Invest, Rheumatol, Madrid, Spain
[3] Univ Camilo Jose Cala, Fac Educ & Salud, Madrid, Spain
关键词
D O I
10.1136/annrheumdis-2019-eular.7177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0246
引用
收藏
页码:1579 / 1580
页数:2
相关论文
共 50 条
  • [1] FATIGUE PATTERNS IN RHEUMATOID ARTHRITIS PATIENTSWHO RECEIVE BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Freites Nunez, Dalifer
    Redondo, Marta
    Font, Judit
    Madrid Garcia, Alfredo
    Vadillo, Cristina
    Abasolo, Lydia
    Leon, Leticia
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1618 - 1619
  • [2] Patterns of Fatigue in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs
    Freites Nunez, Dalifer
    Leon, Leticia
    Redondo, Marta
    Vadillo Font, Cristina
    Lois, Pia
    Mucientes Ruiz, Arkaitz
    Rodriguez-Rodriguez, Luis
    Fernandez Gutierrez, Benjamin
    Jover Jover, Juan Angel
    Abasolo Alcazar, Lydia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Safety of biological disease-modifying antirheumatic drugs in rheumatoid arthritis
    Martinez-Mugica, Cristina
    Salgueiro, Esther
    [J]. FARMACIA HOSPITALARIA, 2022, 46 (01) : 15 - 20
  • [4] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
    Smolen, Josef S.
    Landewe, Robert
    Breedveld, Ferdinand C.
    Dougados, Maxime
    Emery, Paul
    Gaujoux-Viala, Cecile
    Gorter, Simone
    Knevel, Rachel
    Nam, Jackie
    Schoels, Monika
    Aletaha, Daniel
    Buch, Maya
    Gossec, Laure
    Huizinga, Tom
    Bijlsma, Johannes W. J. W.
    Burmester, Gerd
    Combe, Bernard
    Cutolo, Maurizio
    Gabay, Cem
    Gomez-Reino, Juan
    Kouloumas, Marios
    Kvien, Tore K.
    Martin-Mola, Emilio
    McInnes, Iain
    Pavelka, Karel
    van Riel, Piet
    Scholte, Marieke
    Scott, David L.
    Sokka, Tuulikki
    Valesini, Guido
    van Vollenhoven, Ronald
    Winthrop, Kevin L.
    Wong, John
    Zink, Angela
    van der Heijde, Desiree
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 964 - 975
  • [5] The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
    Gregory, Fleury
    Sylvano, Mania
    Didier, Hannouche
    Cem, Gabay
    [J]. SWISS MEDICAL WEEKLY, 2017, 147
  • [6] THE LONG-TERM PREDICTORS OF FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Oliveira, D. Santos
    Martins, A.
    Samoes, B.
    Martins, F. R.
    Pinheiro, F. Oliveira
    Rato, M.
    Nicolau, R.
    Vaz, C.
    Bernardes, M.
    Costa, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1224 - 1225
  • [7] Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
    Solomon, Daniel H.
    Tonner, Chris
    Lu, Bing
    Kim, Seoyoung C.
    Ayanian, John Z.
    Brookhart, M. Alan
    Katz, Jeffrey N.
    Yelin, Ed
    [J]. ARTHRITIS CARE & RESEARCH, 2014, 66 (08) : 1152 - 1158
  • [8] Targeted synthetic disease-modifying antirheumatic drugs in spondyloarthritis
    Wendling, Daniel
    Prati, Clement
    [J]. IMMUNOTHERAPY, 2017, 9 (03) : 221 - 223
  • [9] Survival of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Rosales Rosado, Zulema
    Leon, Leticia
    Freites Nunez, Dalifer
    Font Urgelles, Judit
    Leon Cardenas, Cynthia Milagros
    Vadillo Font, Cristina
    Rodriguez Rodriguez, Luis
    Jover Jover, Juan A.
    Abasolo Alcazar, Lydia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Otani, Hiroshi
    Abe, Asami
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    [J]. INTERNAL MEDICINE, 2023, 62 (03) : 373 - 379